Health & Fitness
Mon, February 28, 2011Sun, February 27, 2011Fri, February 25, 2011Thu, February 24, 2011Wed, February 23, 2011Tue, February 22, 2011Mon, February 21, 2011Sun, February 20, 2011Fri, February 18, 2011Thu, February 17, 2011Wed, February 16, 2011Tue, February 15, 2011Mon, February 14, 2011Fri, February 11, 2011Thu, February 10, 2011Biomagnetics to Begin Engineering Phase of Biosensor Development a" Selects Lathrop Engineering for Development
Published in Health and Fitness on Tuesday, February 22nd 2011 at 6:10 GMT by Market Wire
SAN FRANCISCO--([ BUSINESS WIRE ])--Biomagnetics Diagnostics Corp., (PINK SHEETS:[ BMGP ]) a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced it has selected Lathrop Engineering as its vendor to complete product design for the worlda™s first integrated optical biosensor system. Over the coming weeks senior personnel from Lathrop will work with the scientific staff at Los Alamos National Laboratory to receive technical data on the IBOS system to begin production design and miniaturization of the device.
"As the collaborative research and development agreement with LANL nears completion we are aggressively moving to the next phase of development."
aAs the collaborative research and development agreement with LANL nears completion we are aggressively moving to the next phase of development.a Clayton Hardman, president of Biomagnetics continues, aWe have selected one of Silicon Valleya™s top engineering firms, Lathrop Engineering, to complete this critical phase.a
Biomagnetics Diagnostics believes the availability of this portable, handheld technology will substantially lower the cost of, and substantially raise the availability of, malaria, tuberculosis, HIV/AIDS and cholera diagnosis and detection in many areas throughout the world, potentially saving hundreds of thousands of lives each year.
About Biomagnetics Diagnostics Corp.
Biomagnetics Diagnostics Corporation is an advanced medical device and biotechnology company and an acquirer of other innovative technologies. The Companya™s revolutionary diagnostic systems, which are based on advanced waveguide and magnetics technologies, test for any virtually viral or bacterial disease. The Company's technology allows laboratories to perform far more tests in the same amount of time it takes to do a single test. The HTS-MTP platform is designed to detect the actual virus and viral load in body fluids and not just simply screen for the presence of viral antibodies. Additionally, the Company is currently developing a waveguide-based advanced integrated optical biosensor through its cooperative research and development agreement with Los Alamos National Security, LLC, which will initially be used for cholera, tuberculosis and malaria diagnosis. More information on Biomagnetics Diagnostics Corp. can be seen at [ www.Biomagneticsbmgp.com ].
